List of works by Yasuo Terauchi

Achieving LDL-C target levels less than 70 mg/dL may provide extra cardiovascular protection in high-risk patients: exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients With Hypercholesterolemia and Diabetic Retinopathy S

scientific article published on 06 December 2018

Benefits of the fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time-to-control analysis of the LixiLan JP phase 3 trials

scientific article published on 01 September 2020

Causes of death and estimated life expectancy among people with diabetes: A retrospective cohort study in a diabetes clinic

scientific article published on 13 June 2019

Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients

scientific article published on 24 August 2013

Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study Health Study

scientific article published on 30 January 2020

Effectiveness of repeated intragastric balloon therapy in a morbidly obese Japanese patient

scientific article published on 15 January 2011

Effects of ipragliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the multicenter prospective intervention study

scientific article published on 09 March 2020

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: a randomized controlled study ELLENA-IT study

scientific article published on 11 April 2020

Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study:

scientific article published on 14 April 2020

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study

scientific article

Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12-month comparison by concomitant sulphonylurea and/or glinide use

scientific article published on 16 July 2018

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

scientific article published on 25 July 2007

Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.

scientific article published in January 2007

Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine

scientific article

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.

scientific article published on 6 April 2018

Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor

scientific article published on 22 October 2020

Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease

scientific article

Long-term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J-STEP/GLP): a 52-week open-label, multicenter, post-mar

scientific article published on 28 May 2019

Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model

scientific article

Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin

scientific article published on 01 July 2012

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

scientific article published on 11 June 2019

Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway

scientific article

Potential linkage between dipeptidyl peptidase-4 inhibitor use and the risk of pancreatitis/pancreatic cancer

scientific article published on 27 November 2019

Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion

scientific article published in August 2004

Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus

scientific article published on November 2011

Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats

scientific article published on 05 April 2007

The beneficial effects of a muscarinic agonist on pancreatic β-cells

scientific article published on 07 November 2019

The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitus

scientific article published on 03 October 2019

Time-course of changes of visceral fat area, liver volume and liver fat area during intragastric balloon therapy in Japanese super-obese patients

scientific article published on 01 November 2011

Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

scientific article published on 25 May 2007

Paulina is supported by:

About Paulina

Help